‘Highly Problematic’: Acting FDA Commissioner Paused Planned OK Of Novavax Shot

Former Acting FDA Commissioner Sara Brenner is said to have asked Tracy Beth Høeg, new special assistant to the commissioner, to help reexamine the application. Høeg’s position at the agency is raising concerns about the FDA's ongoing approach to vaccine regulation.

Novavax was expected to finally nab full approval of its COVID-19 vaccine on 1 April. (Shutterstock)

More from US FDA

More from Vaccines